Strains of M. tuberculosis resistant to individual drugs arise by spontaneous point mutations in the mycobacterial genome, which occur at low but predictable rates.
Because there is no cross-resistance among the commonly used first line anti-TB drugs, the probability that a strain will be resistant to two drugs is the product of the probabilities of resistance to each drug and thus is quite low. |